Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

The Canadian Biomaterials Society is pleased to present The 2022-2023 CBS mentorship and Professional Development Program Join The 2nd Lab and the CBS-QC Student Chapter this Friday, October 7th, 2022 at 5 00 PM for a hybrid information session about this program...

Dear CBS Members, The World Biomaterials Congress 2024 WBC2024 is soliciting recommendations for plenary speakers...

Through the BioInnovation Institute Science Prize for Innovation, the editors of Science seek to recognize bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship...

We are pleased to open the call for applications for the CBS Mentorship and Professional Development, a program specifically designed to connect professionals outside of academia with graduate students and postdoctoral fellows coming from the Canadian biomaterial s community...

Hospital-acquired infections HAI are a global health concern. Every year, millions of patients are affected...

The naturally derived material small intestinal submucosa SIS is a decellularized and collagen-rich extracellular matrix material derived from the submucosal layer of porcine intestine, is widely used in clinic and preclinic research, since it remains mainly structural and functional molecules of native extracellular matrix ECM , such as collagen, hyaluronic acid, and kinds of growth factors...

Adipose tissue has a high capacity for expansion and regression throughout mammalian life. Nevertheless, following reconstructive surgeries designed to augment adipose depots, or tissue injury, adipose tissue displays limited regenerative capacity, and is instead often replaced with scar tissue...

Bone embrittlement as a result of -irradiation sterilization poses an issue for both tissue banks and orthopedic surgeons...

Lipid-modified low molecular weight polyethyleneimines LMW PEIs are promising non-viral gene delivery systems that have been successfully explored for the treatment of various diseases through the delivery of plasmid DNA pDNA or mRNA to expression therapeutic proteins thereby restoring the defective protein, for the knockdown of aberrant proteins using RNA interference RNAi with short interfering RNA siRNA or for the complete knockout of the gene using CRISPR technology 1, 2 ...